Understanding the Tip:
Why blister integrity matters in photostability studies:
Blister packaging plays a critical role in protecting pharmaceutical tablets and capsules from environmental factors—especially light. Over time, blisters may become punctured, cracked, or compromised during distribution and handling. Photostability testing that only evaluates intact blisters may underestimate the risk of product degradation if exposed due to blister damage. Including comparisons between intact and intentionally broken blister units simulates real-world risk and enhances the robustness of the stability evaluation.
Potential degradation risks from blister breaches:
Broken or partially opened blisters can lead to:
- Direct exposure of the drug product to UV and visible light
- Accelerated degradation of light-sensitive APIs or colorants
- Loss of potency or appearance changes (e.g., fading, discoloration)
- Inconsistent product performance or shelf-life reduction
Evaluating these risks under photostability protocols allows for informed decisions on packaging materials, labeling, and patient-use instructions.
Regulatory and Technical Context:
ICH and WHO guidelines on light exposure studies:
ICH Q1B mandates that light testing should demonstrate that the drug substance and drug product are not adversely affected by light, or that appropriate protective packaging is provided. WHO TRS 1010 also emphasizes packaging integrity in photostability evaluations. Including both intact and breached blister comparisons provides evidence that the packaging is essential and effective in light shielding—and reveals vulnerabilities when compromised.
Impact on regulatory filings and inspections:
In CTD Module 3.2.P.8.3, photostability results must support the packaging choice and any product storage label claims (e.g., “Store in the original package to protect from light”). If only intact blisters are tested, regulators may question the real-life applicability of the data. Including broken blister samples proactively addresses this concern and reduces queries during submission reviews or inspections.
Best Practices and Implementation:
Design side-by-side photostability studies:
Include two sets of samples:
- Blisters in original, sealed condition
- Blisters intentionally broken or pierced to simulate handling damage
Expose both sets to ICH Q1B light conditions (1.2 million lux hours and 200 W•h/m² UV energy) and evaluate key parameters such as assay, impurities, color, disintegration, and physical integrity.
Use visual and analytical comparisons to draw conclusions:
Document:
- Any color change or surface degradation
- Change in impurity profile or degradation peak appearance
- Difference in assay values compared to protected controls
Photographic evidence, chromatographic overlays, and statistical summaries help clearly demonstrate the protection offered by intact packaging and the risk posed by damaged blisters.
Incorporate findings into packaging design and labeling:
If broken blister samples show significant degradation:
- Reinforce primary packaging (e.g., aluminum-aluminum blisters)
- Add package inserts warning against blister tampering
- Include “store in the original package” or “protect from light” in product labeling
Document your findings in regulatory filings and include them in your product lifecycle and change control strategies for packaging updates.
Comparing intact vs. broken blister units in photostability testing ensures your product is truly protected throughout its lifecycle—not just in ideal conditions—and helps your team meet both regulatory expectations and real-world performance standards.